Mutares Faces AGM Test With No Performance Dividend but a Defense IPO on the Horizon

Mutares stock closes above key resistance ahead of July 3 AGM; dividend proposal and defense subsidiary growth in focus as exit pipeline accelerates.

Mutares shares have nudged back above a key technical level, but the real reckoning for management comes on July 3, when shareholders gather for the annual meeting. The stock closed Friday at €29.40 after a 3.70% daily gain, placing it just above the 200-day moving average of €28.96 – a line that had acted as resistance for months. The recovery from the April trough of €23.30 amounts to a 26% rebound, and the relative strength index of 63.5 suggests there is still room to run before hitting overbought territory. Yet the path back to the 52-week high of €36.75 remains a 20% climb, and the market is not handing it out for free.

The central tension on the AGM agenda is the dividend proposal. Management and the supervisory board recommend a payout of €2.00 per share, which Mutares explicitly labels a “minimum dividend.” The company’s model promises an additional performance dividend when exits generate substantial profit and cash. Despite 2025 being a breakout year operationally – group revenue hit €6.5 billion, and EBITDA surged from €117 million to €675 million – no extra payout is forthcoming. That decision is bound to draw pointed questions from investors who have watched the exit machine grind through a series of disposals without triggering a special distribution.

The exit pipeline is indeed humming. In June, Mutares agreed to sell NEM Energy B.V. and its subsidiary NEM Balcke-Dürr to Hyundai Heavy Industries Power Systems, a deal expected to close in the third quarter pending regulatory clearance. NEM was acquired from Siemens Energy in late 2022 and turned into a profitable standalone platform – a textbook example of the buy-fix-sell playbook. That follows the earlier exits of Terranor, Walor Precision Turning, and parts of the F.lli Ferrari business. In the first quarter alone, Mutares completed three acquisitions and six divestments. Yet the share price has not caught up with the activity.

Warburg Research recently trimmed its price target to €41 from €46 while keeping a buy recommendation. The downgrade reflects a more cautious near-term outlook, but the underlying thesis remains intact: the deal engine works. The problem is that the market is pricing in the cyclical volatility that comes with a model where years of heavy exits produce fat profits and years of building portfolios look lean. That earnings lumpiness has kept Mutares among the most cheaply valued stocks in the SDAX, and it explains why the typical valuation re-rating has yet to materialize.

The most powerful potential catalyst sits in Mutares’ defense subsidiary. Magirus – now rebranded Magirus Defense Systems after the October 2025 acquisition of Achleitner Fahrzeugbau – generated roughly €85 million in revenue in the first quarter of 2026, with an order backlog exceeding €880 million. Full-year 2025 revenue reached €336 million, and adjusted EBIT improved markedly. The company is targeting the red-hot defense and security infrastructure market, and a major order for the Survivor vehicle platform underscores the growth trajectory. Management has explicitly said that an initial public offering for Magirus is under consideration. A listing in this environment could unlock a valuation multiple far higher than the parent’s current compressed rating.

But Mutares must first clean up its balance sheet. Outstanding bonds totaled €385 million at the end of 2025, and the company aims to reduce that to €300 million by year-end. It also breached a key leverage covenant last year, and management expects to restore compliance by June 30, 2026. For the current fiscal year, the holding company targets a net profit of €165 million to €200 million on group revenue between €7.9 billion and €9.1 billion. Exit proceeds are projected to significantly exceed the roughly €230 million recorded in 2025.

The AGM on July 3 thus serves as more than a procedural vote. It is a moment for the board to explain why the surging exit activity has not translated into a performance dividend, and to convince skeptics that the financial house is in order. The Mindestdividende alone provides a yield that is respectable at the current price, but it will not carry the stock back toward the highs. That job falls to the exit pipeline – and above all to the Magirus defense story. If management can show that the IPO process is advancing and that the balance sheet repair stays on schedule, the market may finally start pricing in the upside that the deal machine is producing. Until then, the shares remain an asymmetric bet on a company that is doing all the right things but struggling to get the recognition it deserves.